Related Experiment Video
Updated: Jul 31, 2025
06:27
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
491
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Biorxiv : the Preprint Server for Biology
|May 3, 2023
Summary
ATRX loss primes glioma cells for innate immune activation, but IDH1 mutation masks this response. Reversible IDH1 inhibition restores immune sensitivity, revealing a therapeutic vulnerability in astrocytoma.
Area of Science:
- Neuro-oncology
- Immunology
- Cancer Biology
Background:
- Innate immune stimulation is a potential glioma therapy.
- ATRX mutations in IDH-mutant astrocytomas are linked to immune dysfunction.
- The interplay between ATRX loss and IDH mutation in innate immunity is poorly understood.
Conclusions:
- ATRX loss sensitizes glioma cells to dsRNA recognition, priming them for immune attack.
- IDH1R132H mutation reversibly masks this immune priming.
- Innate immunity represents a druggable vulnerability in astrocytoma.
More Related Videos
09:43Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
8.1K
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.4K
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:31The Intrinsic Apoptotic Pathway
6.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K